Ovarian cancer treatment on trial
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A breakthrough in the treatment of ovarian cancer is this week being trialled in Britain. It could save the lives of thousands of women, medical researchers believe.
A joint British-Canadian trial of the new technique, known as intraperitoneal chemotherapy, will be launched at Barts and The London School of Medicine and Dentistry. Dr Chris Gallagher, who heads the study in the UK, is confident it will show an increase in survival of around 20 per cent.
Ovarian cancer is the fourth most deadly cancer in women in the UK. Dr Gallagher said: "Ovarian cancer tends to spread, or recur, within the abdominal cavity. This way, we have the potential to expose the tumour to much higher concentrations of the drug."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments